Center for Health Equity Research and Promotion
Peter Groeneveld, MD, MS
CHERP COIN Investigator
Associate Director, CHERP
Attending Physician, Corporal Michael J. Crescenz (Philadelphia) VA Medical Center
Chair, Research and Development Committee, Crescenz (Philadelphia) VA Medical Center
Professor of Medicine, University of Pennsylvania's Perelman School of Medicine
Director of Research, Leonard Davis Institute for Health Economics
Dr. Groeneveld's research is focused on the comparative effectiveness, clinical outcomes, economics, and social consequences of health care technology, with a particular focus in cardiovascular disease. A central aim of his research is to improve the value of high-technology healthcare by illuminating opportunities to expand the use of technology in settings where it can provide substantial health benefits relative to cost, and by indentifying instances of technology overuse. An additional aim is to enhance the equity of the U.S. healthcare system by demonstrating how the increasing complexity and cost inherent in many new technologies can worsen long-established disparities in health care quality between white and minority patients.
Dr. Groeneveld is a former VA HSR&D Research Career Development Awardee, and he has been the PI on two HSR&D Merit Review Awards as well as several other studies funded by the VA, NIH, and AHRQ.
Dr. Groeneveld is a primary care physician at the Corporal Michael J. Crescenz VA Medical Center (CMCVAMC), and he also Chairs the CMCVAMC Research and Development Committee. He is a Fellow of the American College of Physicians and of the American Heart Association, and he is an elected member of the American Society for Clinical Investigation.
- Director, Cardiovascular Outcomes, Quality, and Evaluative Research (CAVOQER)
- Center, University of Pennsylvania
- Director of Research, Leonard Davis Institute, University of Pennsylvania
- Co-Director, Master of Science in Health Policy Research, University of Pennsylvania.
Published ResearchFederal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System. JAMA Network Open (2020)
Federal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System. JAMA Network Open (2020)
Quality and value of health care in the Veterans Health Administration: a qualitative study. Journal American Heart Association (2019)
Federal payments for coronary revascularization procedures among dual enrollees in Medicare Advantage and the Veterans Affairs health care system. JAMA Network Open (2019)
Association between spending and survival of chronic heart failure across Veterans Affairs Medical Centers. JAMA Network Open (2019)
Trends in catheter-directed thrombolysis and systemic thrombolysis for the treatment of pulmonary embolism. Am Heart J (2019)
Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016. Circ Cardiovasc Interv (2019)
Outcomes of care for ischemic heart disease and chronic heart failure in the Veterans Health Administration. JAMA Cardiology (2018)
Characterizing Tweet Volume and Content About Common Health Conditions Across Pennsylvania: Retrospective Analysis. JMIR Public Health Surveill (2018)
Ensuring Optimal Adjustment for Determinations of Institutional Quality-Reply. JAMA Cardiol (2018)
One-Year Cardiovascular Outcomes in Patients With Peripartum Cardiomyopathy. J Card Fail (2018)
Comparative outcomes after percutaneous coronary intervention among black and white patients treated at US Veterans Affairs hospitals. JAMA Cardiology (2017)
- Healthcare Technology